Literature DB >> 19727611

Targeting the purinome.

Jeremy M Murray1, Dirksen E Bussiere.   

Abstract

Purines are critical cofactors in the enzymatic reactions that create and maintain living organisms. In humans, there are approximately 3,266 proteins that utilize purine cofactors and these proteins constitute the so-called purinome. The human purinome encompasses a wide-ranging functional repertoire and many of these proteins are attractive drug targets. For example, it is estimated that 30% of modern drug discovery projects target protein kinases and that modulators of small G-proteins comprise more than 50% of currently marketed drugs. Given the importance of purine-binding proteins to drug discovery, the following review will discuss the forces that mediate protein:purine recognition, the factors that determine druggability of a protein target, and the process of structure-based drug design. A review of purine recognition in representatives of the various purine-binding protein families, as well as the challenges faced in targeting members of the purinome in drug discovery campaigns will also be given.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727611     DOI: 10.1007/978-1-60761-274-2_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  An organometallic inhibitor for the human repair enzyme 7,8-dihydro-8-oxoguanosine triphosphatase.

Authors:  Manuel Streib; Katja Kräling; Kristin Richter; Xiulan Xie; Holger Steuber; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-20       Impact factor: 15.336

Review 2.  Therapeutic potential for P2Y2 receptor antagonism.

Authors:  Kimberly J Jasmer; Kevin Muñoz Forti; Lucas T Woods; Seunghee Cha; Gary A Weisman
Journal:  Purinergic Signal       Date:  2022-10-11       Impact factor: 3.950

Review 3.  The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Authors:  Davide Ferrari; Michele Rubini; Jorge S Burns
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

4.  Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.

Authors:  Dirksen E Bussiere; Lili Xie; Honnappa Srinivas; Wei Shu; Ashley Burke; Celine Be; Junping Zhao; Adarsh Godbole; Dan King; Rajeshri G Karki; Viktor Hornak; Fangmin Xu; Jennifer Cobb; Nathalie Carte; Andreas O Frank; Alexandra Frommlet; Patrick Graff; Mark Knapp; Aleem Fazal; Barun Okram; Songchun Jiang; Pierre-Yves Michellys; Rohan Beckwith; Hans Voshol; Christian Wiesmann; Jonathan M Solomon; Joshiawa Paulk
Journal:  Nat Chem Biol       Date:  2019-12-09       Impact factor: 15.040

Review 5.  In Search of a Role for Extracellular Purine Enzymes in Bone Function.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio
Journal:  Biomolecules       Date:  2021-04-30

Review 6.  John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Silvia Paoletta; Evgeny Kiselev; Saibal Chakraborty; P Suresh Jayasekara; Ramachandran Balasubramanian; Dilip K Tosh
Journal:  Comput Struct Biotechnol J       Date:  2014-10-16       Impact factor: 7.271

7.  A naturally occurring, noncanonical GTP aptamer made of simple tandem repeats.

Authors:  Edward A Curtis; David R Liu
Journal:  RNA Biol       Date:  2014-04-24       Impact factor: 4.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.